Skip to search formSkip to main contentSkip to account menu

CardioSeal Septal Occluder

Known as: CardioSeal Septal Occluders, Septal Occluders, CardioSeal, Septal Occluder, CardioSeal 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Septal Occluder Device

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.
AIMS Percutaneous patent foramen ovale (PFO) closure for secondary stroke prevention is discussed controversially. Long-term data… 
Highly Cited
2008
Highly Cited
2008
Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder).
2008
2008
Late presentation of CardioSEAL PFO closure device fracture and thrombus formation three years after device implantation.
Transcatheter closure of patent foramen ovale (PFO) is a promising alternative to surgical closure or anticoagulation therapy in… 
Highly Cited
2004
Highly Cited
2004
Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems.
2004
2004
CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects
2004
2004
CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects.
2002
2002
[Interventional occlusion of foramen ovale and atrial septal defects after paradoxical embolism incidents].
Two hundred and fifty-one patients with a persistent foramen ovale (PFO), mean age 43.3 +/- 12.4 years, underwent catheter… 
2002
2002
Interventioneller Verschluss von Foramen ovale und Vorhofseptumdefekten nach paradox embolischen Ereignissen
Two hundred and fifty-one patients with a persistent foramen ovale (PFO), mean age 43.3±12.4 years, underwent catheter closure… 
Highly Cited
2001
Highly Cited
2001
Patent foramen ovale closure in patients with transient ischemia attack/stroke.
Paradoxical embolism through a patent foramen ovale (PFO) has been recognized as a potential cause of transient ischemia attack… 
Highly Cited
2001
Highly Cited
2001
Catheter closure of atrial septal defects and patent foramen ovale in patients with an atrial septal aneurysm using different devices.
BACKGROUND Atrial septal aneurysm is frequently associated with patent foramen ovale (PFO) and atrial septal defects (ASD… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)